We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Requests Meeting With Medtronic After Pump Flaws Cited in Warning Letter
FDA Requests Meeting With Medtronic After Pump Flaws Cited in Warning Letter
September 6, 2012
Medtronic officials will meet Sept. 7 with FDA staff to discuss problems related to faulty SynchroMed II pumps and possible corrective actions, company spokeswoman Donna Marquard told GMP.